Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution
暂无分享,去创建一个
Henrik Zetterberg | Mathew H Horrocks | David Klenerman | Georg Meisl | Tuomas P J Knowles | D. Klenerman | H. Zetterberg | M. Horrocks | T. Knowles | G. Meisl | Christopher G Taylor | Christopher G. Taylor
[1] M. Leone,et al. Thioflavin T Promotes Aβ(1-40) Amyloid Fibrils Formation. , 2012, The journal of physical chemistry letters.
[2] V. Subramaniam,et al. Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .
[3] A. Bonnet,et al. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death , 2010, Neurobiology of Aging.
[4] Alexander K. Buell,et al. Spatial propagation of protein polymerization. , 2014, Physical review letters.
[5] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[6] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[7] Mathew H Horrocks,et al. A mechanistic model of tau amyloid aggregation based on direct observation of oligomers , 2015, Nature Communications.
[8] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[9] T. Tokuda,et al. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease , 2010, Neurology.
[10] Richard W. Clarke,et al. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence , 2008, Proceedings of the National Academy of Sciences.
[11] N. Cairns,et al. The Structural Basis for Optimal Performance of Oligothiophene-Based Fluorescent Amyloid Ligands: Conformational Flexibility is Essential for Spectral Assignment of a Diversity of Protein Aggregates , 2013, Chemistry.
[12] K. Blennow,et al. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.
[13] M. Spillantini,et al. pFTAA: a high affinity oligothiophene probe that detects filamentous tau in vivo and in cultured neurons , 2015, Neural regeneration research.
[14] P. Kingshott,et al. Protein aggregation and degradation during iodine labeling and its consequences for protein adsorption to biomaterials. , 2007, Analytical biochemistry.
[15] Jeffrey H. Kordower,et al. The role of α-synuclein in Parkinson's disease: insights from animal models , 2003, Nature Reviews Neuroscience.
[16] C. Dobson,et al. Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of α-synuclein oligomers. , 2015, Analytical chemistry.
[17] C. Dobson,et al. Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells , 2016, Scientific Reports.
[18] V. Uversky,et al. Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique , 2012, PloS one.
[19] Jianmin Gao,et al. Highly sensitive amyloid detection enabled by thioflavin T dimers. , 2010, Molecular bioSystems.
[20] Christopher M. Dobson,et al. Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.
[21] Christopher M. Dobson,et al. Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids , 2016, ACS chemical neuroscience.
[22] V. Uversky,et al. Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity. , 2008, The journal of physical chemistry. B.
[23] Hitoshi Takahashi,et al. The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.
[24] Henry Pinkard,et al. Advanced methods of microscope control using μManager software. , 2014, Journal of biological methods.
[25] D. Armbruster,et al. Limit of blank, limit of detection and limit of quantitation. , 2008, The Clinical biochemist. Reviews.
[26] A. Levey,et al. Proteomic identification of novel proteins associated with Lewy bodies. , 2008, Frontiers in bioscience : a journal and virtual library.
[27] S. Nath,et al. PicoGreen: a better amyloid probe than Thioflavin-T. , 2016, Chemical communications.
[28] Satoshi Takahashi,et al. Direct Observation of Aβ Amyloid Fibril Growth and Inhibition , 2004 .
[29] M. Groenning,et al. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status , 2010, Journal of chemical biology.
[30] Liming Ying,et al. Ultrasensitive coincidence fluorescence detection of single DNA molecules. , 2003, Analytical chemistry.
[31] A. Abate,et al. Observation of spatial propagation of amyloid assembly from single nuclei , 2011, Proceedings of the National Academy of Sciences.
[32] D. Teplow,et al. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.
[33] K. Jacobson,et al. Single-particle tracking: applications to membrane dynamics. , 1997, Annual review of biophysics and biomolecular structure.
[34] P. Hof,et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. , 2009, ACS chemical biology.
[35] T. S. West. Analytical Chemistry , 1969, Nature.
[36] Tuomas P. J. Knowles,et al. Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading , 2016, Proceedings of the National Academy of Sciences.
[37] W. K. Cullen,et al. Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.
[38] M. Maurin,et al. REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .